13.000
+0,00%
2026-10-15
Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -12.9% | +5.0% | 1 / 3 | +0.9% | -0.54 pp | -0.89 pp | +5.3% | 0.00 | 11.40 | 24,1 | +0,9% | 1,4 | −12,9% | 11.40 | 8.71 | +30,9% |
| Pts | 0 | 0 | 4 | 0 | 4 | 4 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 13.000 (close price on 2026-10-15)EPS (TTM): 1.140
Financial charts
1.Revenue & growth
VND bn24,1Q2/26
1.Revenue & growth
VND bn24,1Q2/26
2.Profit & growth
VND bn1,36Q2/26
3.Profit mix (Penman)
VND bn2,78Q2/26
4.Margins & cost structure
%26.9%Q2/26
5.Returns & cash cycle
% · days4.7%Q2/26
6.Earnings quality & cash
VND bn2,42Q2/26
7.Asset structure
VND bn59,5Q2/26
8.Funding & debt health
VND bn · times59,5Q2/26
9.Revenue backlog
VND bn0,26Q2/26
10.Valuation
times · %11,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %704Q2/26
Adjusted EPS growth, latest quarter
-12.9%
Average adjusted EPS growth, 3 quarters
-28.0%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26